Neuromodulation Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Spinal Cord Stimulation, Deep Brain Stimulation, and 3 more
- Year: 2023
- Scope: 10 Years
- Region: Global
- Pages: 112
- Published Date: 03/21/2023
- Type: MedCore
Overall, the global neuromodulation device market was valued at $4.9 billion in 2022. This is expected to increase over the forecast period at a CAGR of 7.4% to reach $8.2 billion.
The full report suite on the global neuromodulation device market includes spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric electric stimulation.
MARKET REPORT DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2029, and Historical Data to 2019
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL NEUROMODULATION DEVICE MARKET INSIGHTS
One of the main market drivers is the technological advancement of neuromodulation devices. Prolonged battery life in implantable, rechargeable spinal cord stimulation is an attractive option for patients. Several manufacturers boast battery lifetimes from five to nine years but are seeking support from the FDA for longer battery life claims.
GLOBAL NEUROMODULATION DEVICE MARKET SHARE INSIGHTS
Within the global market for neuromodulation devices, there are three key market players – Medtronic, Boston Scientific, Abbott.
In 2022, Medtronic was the leader in the global neuromodulation market. The company competes with its InterStim™ therapy system product line. Boston Scientific was the second-leading competitor in the neuromodulation device market in 2022. Abbott held the third-leading position in the neuromodulation device market.
MARKET SEGMENTATION SUMMARY
- Global Spinal Cord Stimulation Market
- Global Deep Brain Stimulation Market
- Global Sacral Nerve Stimulation Market
- Global Vagus Nerve Stimulation Market
- Global Gastric Electric Stimulation Market
RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.) Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam) Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2022 |
| Forecast | 2023-2029 |
| Historical Data | 2019-2022 |
| Quantitative Coverage | Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
| Neuromodulation Device Market |
| 14.1 Executive Summary |
| 14.1.1 Global Neuromodulation Device Market Overview |
| 14.1.2 Competitive Analysis |
| 14.1.3 Markets Included |
| 14.1.4 Regions Included |
| 14.2 Introduction |
| 14.2.1 Spinal Cord Stimulation |
| 14.2.2 Deep Brain Stimulation |
| 14.2.3 Sacral Nerve Stimulation |
| 14.2.4 Vagus Nerve Stimulation |
| 14.2.5 Gastric Electric Stimulation |
| 14.3 Procedure Numbers |
| 14.3.1 Total Neuromodulation Procedures |
| 14.3.2 Spinal Cord Stimulation Procedures |
| 14.3.3 Deep Brain Stimulation Procedures |
| 14.3.4 Sacral Nerve Stimulation Procedures |
| 14.3.5 Vagus Nerve Stimulation Procedures |
| 14.3.6 Gastric Electric Stimulation Procedures |
| 14.4 Market Overview |
| 14.4.1 By Segment |
| 14.4.2 By Region |
| 14.5 Market Analysis and Forecast |
| 14.5.1 Total Neuromodulation Device Market |
| 14.5.2 Spinal Cord Stimulation Market |
| 14.5.3 Deep Brain Stimulation Market |
| 14.5.4 Sacral Nerve Stimulation Market |
| 14.5.5 Vagus Nerve Stimulation Market |
| 14.5.6 Gastric Electric Stimulation Market |
| 14.6 Drivers and Limiters |
| 14.6.1 Market Drivers |
| 14.6.2 Market Limiters |
| 14.7 Competitive Market Share Analysis |
Companies Included:
| Medtronic |
| Boston Scientific |
| Abbott |
| LivaNova |
| Nevro |
| Axonics |
| Others include: Cirtec, Cyberonics, EnteroMedics, Imthera, Inspire Medical, IntraPace, NeuroPace, Nevro Corp., Nuvectra, Reshape Lifesciences, SceneRay, etc. |
List of Charts
| Chart 14‑1: Neuromodulation Device Market, Global, 2022 & 2029 |
| Chart 14‑2: Neuromodulation Device Procedures, Global, 2022 |
| Chart 14‑3: Total Neuromodulation Procedures by Region, Global, 2019 – 2029 |
| Chart 14‑4: Neuromodulation Device Market by Region, Global, 2019 – 2029 |
| Chart 14‑5: Leading Competitors, Neuromodulation Device Market, Global, 2022 |
List of Figures
| Figure 14‑1: Neuromodulation Device Markets Covered |
| Figure 14‑2: Neuromodulation Device Regions Covered, Global (1 of 2) |
| Figure 14‑3: Neuromodulation Device Regions Covered, Global (2 of 2) |
| Figure 14‑4: Total Neuromodulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑5: Total Neuromodulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑6: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑7: Total Neuromodulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑8: Total Neuromodulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑9: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑10: Total Neuromodulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑11: Total Neuromodulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑12: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑13: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑14: Total Neuromodulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑15: Total Neuromodulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑16: Spinal Cord Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑17: Spinal Cord Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑18: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑19: Spinal Cord Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑20: Spinal Cord Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑21: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑22: Spinal Cord Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑23: Spinal Cord Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑24: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑25: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑26: Spinal Cord Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑27: Spinal Cord Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑28: Deep Brain Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑29: Deep Brain Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑30: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑31: Deep Brain Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑32: Deep Brain Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑33: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑34: Deep Brain Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑35: Deep Brain Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑36: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑37: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑38: Deep Brain Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑39: Deep Brain Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑40: Sacral Nerve Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑41: Sacral Nerve Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑42: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑43: Sacral Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑44: Sacral Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑45: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑46: Sacral Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑47: Sacral Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑48: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑49: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑50: Sacral Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑51: Sacral Nerve Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑52: Vagus Nerve Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑53: Vagus Nerve Stimulation Procedures by Country, North America, 2019 – 2029 |
| Figure 14‑54: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (1 of 2) |
| Figure 14‑55: Vagus Nerve Stimulation Procedures by Country, Latin America, 2019 – 2029 (2 of 2) |
| Figure 14‑56: Vagus Nerve Stimulation Procedures by Country, Western Europe, 2019 – 2029 |
| Figure 14‑57: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (1 of 2) |
| Figure 14‑58: Vagus Nerve Stimulation Procedures by Country, Central & Eastern Europe, 2019 – 2029 (2 of 2) |
| Figure 14‑59: Vagus Nerve Stimulation Procedures by Country, Middle East, 2019 – 2029 |
| Figure 14‑60: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (1 of 3) |
| Figure 14‑61: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (2 of 3) |
| Figure 14‑62: Vagus Nerve Stimulation Procedures by Country, Asia-Pacific, 2019 – 2029 (3 of 3) |
| Figure 14‑63: Vagus Nerve Stimulation Procedures by Country, Africa, 2019 – 2029 |
| Figure 14‑64: Gastric Electric Stimulation Procedures by Region, Global, 2019 – 2029 |
| Figure 14‑65: Neuromodulation Device Market by Segment, Global, 2019 – 2029 (US$M) |
| Figure 14‑66: Neuromodulation Device Market by Region, Global, 2019 – 2029 (US$M) |
| Figure 14‑67: Neuromodulation Device Market, Global, 2019 – 2029 |
| Figure 14‑68: Units Sold by Region, Neuromodulation Device Market, Global, 2019 – 2029 |
| Figure 14‑69: Average Selling Price by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$) |
| Figure 14‑70: Market Value by Region, Neuromodulation Device Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑71: Spinal Cord Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑72: Units Sold by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑73: Average Selling Price by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑74: Market Value by Region, Spinal Cord Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑75: Deep Brain Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑76: Units Sold by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑77: Average Selling Price by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑78: Market Value by Region, Deep Brain Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑79: Sacral Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑80: Units Sold by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑81: Average Selling Price by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑82: Market Value by Region, Sacral Nerve Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑83: Vagus Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑84: Units Sold by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑85: Average Selling Price by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑86: Market Value by Region, Vagus Nerve Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑87: Gastric Electric Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑88: Units Sold by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 |
| Figure 14‑89: Average Selling Price by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$) |
| Figure 14‑90: Market Value by Region, Gastric Electric Stimulation Market, Global, 2019 – 2029 (US$M) |
| Figure 14‑91: Leading Competitors, Neuromodulation Device Market, Global, 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
| Report Summary | FREE |
Neuromodulation Device Market Size, Share & Trends Analysis | Global | 2023-2029 | MedSuite | Includes: Spinal Cord Stimulation, Deep Brain Stimulation, and 3 more
$4,995 – $9,995
The full report suite on the global neuromodulation device market includes spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation and gastric electric stimulation.
- 2023
- 10 Years
- Global
- 03/21/2023
- 112
- MedCore
Related Reports
